Navigation Links
Cell Therapeutics and Spectrum Pharmaceuticals Close Transaction Forming Joint Venture to Market Zevalin in the US
Date:12/16/2008

s also indicated, under accelerated approval, for the treatment of relapsed or refractory, rituximab-naive, low-grade and follicular NHL based on studies using a surrogate endpoint of overall response rate. It was approved by the FDA in February of 2002 as the first radioimmunotherapeutic agent for the treatment of NHL.

Rare deaths associated with an infusion reaction symptom complex have occurred within 24 hours of rituximab (Rituxan(R)) infusions. Yttrium-90 Zevalin administration results in severe and prolonged cytopenias in most patients. Severe cutaneous and mucocutaneous reactions have been reported. The most serious adverse reactions of the Zevalin therapeutic regimen were primarily hematologic, including neutropenia, thrombocytopenia and anemia. Infusion-related toxicities were associated with pre-administration of rituximab. The risk of hematologic toxicity correlated with the degree of bone marrow involvement prior to Zevalin therapy. Myelodysplasia or acute myelogenous leukemia was observed in 2 percent of patients (8 to 34 months after treatment). Zevalin should only be used by health care professionals qualified by training and experience in the safe use of radionuclides.

Patients and healthcare professionals can visit http://www.zevalin.com for more information.

About Non-Hodgkin's Lymphoma

Non-Hodgkin's lymphoma (NHL) is caused by the abnormal proliferation of white blood cells and normally spreads through the lymphatic system, a system of vessels that drains fluid from the body. NHL can be broadly classified into two main forms -- aggressive NHL, a rapidly spreading acute form of the disease, and indolent NHL, which progresses more slowly. According to the National Cancer Institute's SEER database there were nearly 400,000 people in the U.S. with NHL in 2004. The American Cancer Society estimates that in the United Stat
'/>"/>

SOURCE Cell Therapeutics, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. Pain Therapeutics Receives Complete Response Letter From FDA for REMOXY(R)
2. Prime Therapeutics Announces Blue Cross and Blue Shield of Montana as a Pharmacy Benefit Services Client
3. Agile Therapeutics Abstracts on Lead Product, AG200-15 Accepted by ACOG
4. Cell Therapeutics, Inc. to Offer to Repurchase up to $124 Million of Its Notes
5. Horizon Therapeutics announces 2 pivotal HZT-501 Phase 3 trials meet primary endpoints
6. Transition Therapeutics Announces Dates for Upcoming Corporate Events
7. Taligen Therapeutics Advances Corporate Growth Plan with Appointment of Jeffrey T. Walsh as Chief Business Officer
8. Precision Therapeutics Secures $43 Million in Venture Capital Funding
9. Nile Therapeutics, Inc. Reports 2008 Third Quarter Financial Results
10. Hyperion Therapeutics Completes Phase 2 Data Analysis and Schedules End of Phase 2 Meeting With FDA for HPN-100 in the Chronic Treatment of Urea Cycle Disorders
11. Transition Therapeutics Announces First Quarter Fiscal 2009 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/21/2015)... April 21, 2015 Now, busy Diet Doc ... the company’s new diet breakfast omelets. Like Diet ... shipped in dry ice and are delivered directly to their ... or southwestern omelets that not only appeal to the taste ... their ideal weight with healthy, low carbohydrate meals. , ...
(Date:4/21/2015)... 2015 Pharmacy point of sale ... year's Independent Pharmacy Cooperative trade show, to be held ... Beach. , Retail Management Solutions recently became an approved ... Mike Gross, VP of Sales and Marketing. Gross says ... pharmacy trade shows in the country -- and this ...
(Date:4/21/2015)... 2015 Lifeguard Master is out with their ... are listed on the Lifeguard Master website and are in ... who want a quality and flexible product during their rescue ... and color Spider Straps are some of the most popular ... of sturdy, heavy nylon” , The Spider Straps are rated ...
(Date:4/21/2015)... 2015 The Northeast Football Clinic (NEFC) ... Academy prep school in Byfield, MA. Applications are being ... boys entering grades 6-12. , The outstanding professional, college, ... fall coaching. , Offensive and defensive linemen ... these the most unsung positions on the field, the ...
(Date:4/21/2015)... Renewable energy, sustainable living, the greening of ... Day topics USM Studios ’ programming covers in ... affect of climate change on the planet, the award-winning ... on the environmental concerns affecting the nation and world ... lifestyles, clean air options, and much more when the ...
Breaking Medicine News(10 mins):Health News:Diet Doc Makes Dieting for People on the Go Easier than ever before with Pre-Packaged Diet Meals, Desserts, Snacks and new Breakfast Omelets 2Health News:Diet Doc Makes Dieting for People on the Go Easier than ever before with Pre-Packaged Diet Meals, Desserts, Snacks and new Breakfast Omelets 3Health News:Diet Doc Makes Dieting for People on the Go Easier than ever before with Pre-Packaged Diet Meals, Desserts, Snacks and new Breakfast Omelets 4Health News:Retail Management Solutions to Attend Upcoming Independent Pharmacy Cooperative Trade Show 2Health News:Retail Management Solutions to Attend Upcoming Independent Pharmacy Cooperative Trade Show 3Health News:New Spider Straps for Spine Boards are Introduced for Easy, Fast, and Convenient Use 2Health News:New Spider Straps for Spine Boards are Introduced for Easy, Fast, and Convenient Use 3Health News:New Spider Straps for Spine Boards are Introduced for Easy, Fast, and Convenient Use 4Health News:US Sports Camps and The Northeast Football Clinic Announce 2015 Lineman/Linebacker Clinic Schedule 2Health News:USM Studios’ Programming Focuses on the Environment 2
... of the protein cyclin E renders the aromatase inhibitor ... researchers from The University of Texas M. D. Anderson ... The M. D. Anderson research, led by Khandan ... Experimental Radiation Oncology and the Hubert L. and Olive ...
... Pointes in new scientific statement , TUESDAY, Feb. 9 ... to be aware that certain medications can cause a ... Pointes (TdP), says a joint scientific statement by the ... , The rhythm disturbance is associated with a drop ...
... , , Recognize Excellence in Reporting, ... March 31 , ALEXANDRIA, Va. , ... media professionals to submit national, state, local and student news ... for the 2010 Media Awards. , Details, including categories and ...
... Ariz. , Feb. 9 The Providence Service Corporation, ... nationwide, today announced that it plans to relocate its corporate headquarters ... Peach Properties, will take over the vacant building at the corner ... Electric Power,s new headquarters. , "This will put two of ...
... ... extensive smile gallery and other resources and tools for patients , ... New York, NY (PRWEB) February 9, 2010 -- Leading ... the launch of its new Web site, www.SmileInTheCity.com . The site boasts simple navigation, ...
... bladder biopsies done in doctor,s office boosted overall spending, ... After Medicare sweetened payments for simple office-based endoscopic procedures, ... more in-office bladder biopsies, but the volume of hospital ... , So, instead of saving money, Medicare expenditures rose ...
Cached Medicine News:Health News:Low forms of cyclin E reduce breast cancer drug's effectiveness 2Health News:Low forms of cyclin E reduce breast cancer drug's effectiveness 3Health News:ICU Patients at Risk for Rare Heart Rhythm Problem 2Health News:Mental Health America Encourages Journalists, Media Professionals to Submit Entries for 2010 Media Awards 2Health News:Mental Health America Encourages Journalists, Media Professionals to Submit Entries for 2010 Media Awards 3Health News:Providence Service Corporation Relocates Corporate Headquarters to Downtown Tucson 2Health News:Providence Service Corporation Relocates Corporate Headquarters to Downtown Tucson 3Health News:Top New York Dentists at Smile in the City Launch New Web Site 2Health News:Medicare Cost-Saving Moves Can Backfire 2Health News:Medicare Cost-Saving Moves Can Backfire 3
(Date:4/20/2015)... YORK , April 20, 2015 This ... and Leasing in US$ Million. The report provides separate ... , Europe , and Rest of ... period 2014 through 2020. Also, a seven-year historic analysis ... are derived from primary and secondary research. Company profiles ...
(Date:4/20/2015)... YORK , April 20, 2015 This report ... Instruments in US$ Million by the following Product Segments: Sphygmomanometers ... and Blood Pressure Transducers. The report provides separate comprehensive analytics ... Japan , Europe , ... Latin America . Annual estimates and forecasts ...
(Date:4/20/2015)... 2015  SillaJen, Inc., a private clinical-stage biotherapeutics ... products for cancer, today announced an oral and ... of the American Association for Cancer Research (AACR) ... of its lead product candidate, Pexa-Vec (JX-594) with ... immunotherapy designed to 1) rapidly de-bulk tumors via ...
Breaking Medicine Technology:World Medical Equipment Rental and Leasing Industry 2World Medical Equipment Rental and Leasing Industry 3World Medical Equipment Rental and Leasing Industry 4World Medical Equipment Rental and Leasing Industry 5World Medical Equipment Rental and Leasing Industry 6World Medical Equipment Rental and Leasing Industry 7World Blood Pressure Monitoring and Measurement Instruments Industry 2World Blood Pressure Monitoring and Measurement Instruments Industry 3World Blood Pressure Monitoring and Measurement Instruments Industry 4World Blood Pressure Monitoring and Measurement Instruments Industry 5World Blood Pressure Monitoring and Measurement Instruments Industry 6World Blood Pressure Monitoring and Measurement Instruments Industry 7World Blood Pressure Monitoring and Measurement Instruments Industry 8World Blood Pressure Monitoring and Measurement Instruments Industry 9World Blood Pressure Monitoring and Measurement Instruments Industry 10World Blood Pressure Monitoring and Measurement Instruments Industry 11World Blood Pressure Monitoring and Measurement Instruments Industry 12World Blood Pressure Monitoring and Measurement Instruments Industry 13World Blood Pressure Monitoring and Measurement Instruments Industry 14World Blood Pressure Monitoring and Measurement Instruments Industry 15World Blood Pressure Monitoring and Measurement Instruments Industry 16World Blood Pressure Monitoring and Measurement Instruments Industry 17World Blood Pressure Monitoring and Measurement Instruments Industry 18World Blood Pressure Monitoring and Measurement Instruments Industry 19World Blood Pressure Monitoring and Measurement Instruments Industry 20World Blood Pressure Monitoring and Measurement Instruments Industry 21World Blood Pressure Monitoring and Measurement Instruments Industry 22World Blood Pressure Monitoring and Measurement Instruments Industry 23World Blood Pressure Monitoring and Measurement Instruments Industry 24World Blood Pressure Monitoring and Measurement Instruments Industry 25World Blood Pressure Monitoring and Measurement Instruments Industry 26World Blood Pressure Monitoring and Measurement Instruments Industry 27World Blood Pressure Monitoring and Measurement Instruments Industry 28SillaJen Presents Data Demonstrating Pexa-Vec Synergy with Angiogenesis Inhibitors: A Collaboration with University of California, San Francisco 2SillaJen Presents Data Demonstrating Pexa-Vec Synergy with Angiogenesis Inhibitors: A Collaboration with University of California, San Francisco 3
... - Neose Technologies,Inc. (Nasdaq GM:NTEC) today ... with its collaborative partner, Novo Nordisk ... at the XXIst,Congress of the International ... Switzerland. The data presented demonstrates that,GlycoPEGylation(TM) ...
... On Wednesday,July 11, 2007, at 1:30 p.m. ... of Cell Therapeutics, Inc.'s (CTI),management team will ... of the interim results of its phase ... which pixantrone is substituted for,doxorubicin in standard ...
Cached Medicine Technology:Neose Announces Presentation of Positive Preclinical Data on,GlycoPEGylated Factor VIIa at the XXI Congress of the International,Society on Thrombosis and Haemostasis 2Cell Therapeutics, Inc. Management to Discuss Today's Announcement,of Interim Pixantrone Study Results 2
... chairs with concave seats and large backrests ... seats, backrests, armrests, and casters and glides. ... performance in a variety of environments including: ... health care and office. • With reinforced ...
... seats and large backrests with lumbar support ... and casters and glides. • Choose the ... variety of environments including: industry, education, laboratory, ... office. • With reinforced nylon base • ...
... with concave seats and large backrests with ... backrests, armrests, and casters and glides. • ... in a variety of environments including: industry, ... care and office. • With cast aluminum ...
... ergonomic chairs with concave seats and ... Select options like seats, backrests, armrests, ... the BE Series for top performance ... industry, education, laboratory, clean room, static ...
Medicine Products: